Abstract
The activity of tyrosine kinases is central to many cellular processes, and accumulating evidence suggests that their role in inflammation is no less profound. Three main tyrosine kinase families, the Src, Tec and Syk kinase families are intimately involved in TLR signalling, the critical first step in cellular recognition of invading pathogens and tissue damage. Their activity results in changes in gene expression in affected cells. Key amongst these genes are the cytokines, which orchestrate both the duration and extent of inflammation. Tyrosine kinases also play important roles in cytokine function, and are implicated in signalling through both pro- and anti-inflammatory cytokines such as TNF, IL-6 and IL-10. Thus, strategies to modulate tyrosine kinase activity have significant therapeutic potential in combating the chronic inflammatory state that is typical of many major health issues that face us today, including Rheumatoid Arthritis, Cardiovascular disease and cancer. Here we review current knowledge of the role of tyrosine kinases in inflammation with particular emphasis on their role in TLR signalling.
Keywords: Inflammation, macrophages, Rheumatoid Arthritis, Tyrosine kinases, cytokines
Current Molecular Medicine
Title: Tyrosine Kinases and Inflammatory Signalling
Volume: 9 Issue: 1
Author(s): Theresa H. Page, Maria Smolinska, Justin Gillespie, Anna M. Urbaniak and Brian M.J. Foxwell
Affiliation:
Keywords: Inflammation, macrophages, Rheumatoid Arthritis, Tyrosine kinases, cytokines
Abstract: The activity of tyrosine kinases is central to many cellular processes, and accumulating evidence suggests that their role in inflammation is no less profound. Three main tyrosine kinase families, the Src, Tec and Syk kinase families are intimately involved in TLR signalling, the critical first step in cellular recognition of invading pathogens and tissue damage. Their activity results in changes in gene expression in affected cells. Key amongst these genes are the cytokines, which orchestrate both the duration and extent of inflammation. Tyrosine kinases also play important roles in cytokine function, and are implicated in signalling through both pro- and anti-inflammatory cytokines such as TNF, IL-6 and IL-10. Thus, strategies to modulate tyrosine kinase activity have significant therapeutic potential in combating the chronic inflammatory state that is typical of many major health issues that face us today, including Rheumatoid Arthritis, Cardiovascular disease and cancer. Here we review current knowledge of the role of tyrosine kinases in inflammation with particular emphasis on their role in TLR signalling.
Export Options
About this article
Cite this article as:
Page H. Theresa, Smolinska Maria, Gillespie Justin, Urbaniak M. Anna and Foxwell M.J. Brian, Tyrosine Kinases and Inflammatory Signalling, Current Molecular Medicine 2009; 9 (1) . https://dx.doi.org/10.2174/156652409787314507
DOI https://dx.doi.org/10.2174/156652409787314507 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis, Biological Evaluation and Pharmacokinetic Studies of Mefenamic Acid - N-Hydroxymethylsuccinimide Ester Prodrug as Safer NSAID
Medicinal Chemistry Functional Evaluation of Anti-TNF-α Affibody Molecules in Biochemical Detection and Inhibition to Signalling Pathways of a Synovial Cell
Current Pharmaceutical Biotechnology Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
Current Pharmaceutical Design Trace Elements Supplementation: Recent Advances and Perspectives
Mini-Reviews in Medicinal Chemistry IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine
Current Pharmaceutical Design Subset Selection and Docking of Human P2X7 Inhibitors
Current Computer-Aided Drug Design Crucial Protein Based Drug Targets and Potential Inhibitors for Osteoporosis: New Hope and Possibilities
Current Drug Targets Inflammatory Diseases - New Compounds and Treatments
Current Organic Chemistry Pentosidine, an Advanced Glycation Endproduct, and Arthritis
Current Rheumatology Reviews Celastrol and Terpenes as Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry Novel Purine Nucleoside Analogues for Hematological Malignancies
Recent Patents on Anti-Cancer Drug Discovery The Role of Integrin-Mediated Cell Adhesion in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Pharmaceutical Design Imaging Methods of Joint Damage in Early Rheumatoid Arthritis
Current Rheumatology Reviews Chemometric Modeling of 5-Phenylthiophenecarboxylic Acid Derivatives as Anti-Rheumatic Agents
Current Computer-Aided Drug Design Systemic Delivery of Curcumin: 21st Century Solutions for an Ancient Conundrum
Current Drug Discovery Technologies Lactones: Generic Inhibitors of Enzymes?
Mini-Reviews in Medicinal Chemistry A Systematic Review on the Sinomenine Derivatives
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Metabolic Disorders, Drug Development, Drug Design and Biomarkers)
Current Pharmaceutical Design Genetic and Molecular Determinants of Atherosclerotic Plaque Instability
Current Vascular Pharmacology Exosome-like Nanoparticles: A New Type of Nanocarrier
Current Medicinal Chemistry